These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2882382)

  • 21. Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia.
    Iosa D; DeQuattro V; Lee DD; Elkayam U; Palmero H
    Am Heart J; 1989 Apr; 117(4):882-7. PubMed ID: 2494874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal manifestations of Chagas' disease.
    de Oliveira RB; Troncon LE; Dantas RO; Menghelli UG
    Am J Gastroenterol; 1998 Jun; 93(6):884-9. PubMed ID: 9647012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased capacity of the coronary arteries in chronic Chagas' heart disease: further support for the neurogenic pathogenesis concept.
    Oliveira JS; dos Santos JC; Muccillo G; Ferreira AL
    Am Heart J; 1985 Feb; 109(2):304-8. PubMed ID: 3155586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of the parasympathetic nervous system in chronic Chagasic heart disease].
    Manço JC; Gallo L; Amorim DS
    Arq Bras Cardiol; 1970 Apr; 23(2):79-84. PubMed ID: 5002442
    [No Abstract]   [Full Text] [Related]  

  • 25. [Maximal functional capacity by ergospirometry in patients with Chagas' disease].
    Mady C; Yazbek Júnior P; Pereira Barretto AC; Saraiva JF; de Brito Vianna C; de Serro Azul LG; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1986 Sep; 47(3):201-5. PubMed ID: 3109355
    [No Abstract]   [Full Text] [Related]  

  • 26. Haptoglobin genotypes in Chagas' disease.
    Jorge SE; Abreu CF; Guariento ME; Sonati Mde F
    Clin Biochem; 2010 Feb; 43(3):314-6. PubMed ID: 19804773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications.
    Rossi MA; Bestetti RB
    Cardiology; 1995; 86(1):1-7. PubMed ID: 7728781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis, management and treatment of chronic Chagas' gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic.
    Pinazo MJ; Cañas E; Elizalde JI; García M; Gascón J; Gimeno F; Gomez J; Guhl F; Ortiz V; Posada Ede J; Puente S; Rezende J; Salas J; Saravia J; Torrico F; Torrus D; Treviño B
    Gastroenterol Hepatol; 2010 Mar; 33(3):191-200. PubMed ID: 19837482
    [No Abstract]   [Full Text] [Related]  

  • 29. Muscle sympathetic nerve activity in patients with Chagas' disease.
    Negrão CE; Santos AC; Rondon MU; Franco FG; Ianni B; Rochitte CE; Braga AM; Oliveira MT; Mady C; Barretto AC; Middlekauff HR
    Int J Cardiol; 2009 Nov; 137(3):252-9. PubMed ID: 18723231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden death in Chagas' disease.
    Rassi A; Rassi SG; Rassi A
    Arq Bras Cardiol; 2001 Jan; 76(1):75-96. PubMed ID: 11175486
    [No Abstract]   [Full Text] [Related]  

  • 31. Valsalva maneuver in chagasic patients with documented past medical history of acute chagasic myocarditis.
    Odreman RO; Dávila DF; Donis JH; Torres A; Ferrer J; Inglessis I
    Int J Cardiol; 2004 Feb; 93(2-3):163-7. PubMed ID: 14975542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chagas' disease and ischemic stroke].
    Carod-Artal FJ
    Neurologia; 2006 Apr; 21(3):135-49. PubMed ID: 16575627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy.
    Cunha AB; Cunha DM; Pedrosa RC; Flammini F; Silva AJ; Saad EA; Kopiler DA
    Rev Port Cardiol; 2003 Jan; 22(1):29-52. PubMed ID: 12712809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas's heart disease.
    Marin-Neto JA; Maciel BC; Gallo Júnior L; Junqueira Júnior LF; Amorim DS
    Br Heart J; 1986 Feb; 55(2):204-10. PubMed ID: 3942654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastrointestinal Chagas' disease in Chile].
    Atías A
    Bol Chil Parasitol; 1969; 24(1):70-4. PubMed ID: 4983557
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of sympathetic activation on heart rate variability in Chagas' patients.
    Guzzetti S; Josa D; Pecis M; Bonura L; Prosdocimi M; Malliani A
    J Auton Nerv Syst; 1990 Jul; 30 Suppl():S79-81. PubMed ID: 2212496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parasympathetic denervation and myocardial hypertrophy in chronic Chagas' disease].
    Chapadeiro E; Lopes ER; Pereira FE
    Rev Inst Med Trop Sao Paulo; 1967; 9(1):40-2. PubMed ID: 4970707
    [No Abstract]   [Full Text] [Related]  

  • 38. Chagas' heart disease and the autonomic nervous system.
    Dávila DF; Inglessis G; Mazzei de Dávila CA
    Int J Cardiol; 1998 Sep; 66(2):123-7. PubMed ID: 9829322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chagas' disease. A disease. A disease of the nervous system?].
    Amorim DS; Godoy RA; Manço JC; Gallo Júnior L
    Arq Bras Cardiol; 1968 Jun; 21(3):203-14. PubMed ID: 4984725
    [No Abstract]   [Full Text] [Related]  

  • 40. Subtle cardiac autonomic impairment in Chagas' disease detected by baroreflex sensitivity testing.
    Junqueira Júnior LF; Gallo Júnior L; Manço JC; Marin-Neto JA; Amorim DS
    Braz J Med Biol Res; 1985; 18(2):171-8. PubMed ID: 3830283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.